(Q37877263)

24 August 2017

1 reference

title

Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation (English)

1 reference

24 August 2017

0 references

organ transplantation

1 reference

1

Stanley C Jordan

1 reference

24 August 2017

Mieko Toyoda

2

1 reference

24 August 2017

Ashley A Vo

series ordinal

3

1 reference

24 August 2017

publication date

1 May 2011

1 reference

Expert Review of Clinical Immunology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

341-348

1 reference

Anti-inflammatory actions of intravenous immunoglobulin

24 August 2017

cites work

1 reference

Common variable immune deficiency and autoimmunity

21 January 2018

1 reference

Modulation of the cellular immune system by intravenous immunoglobulin

21 January 2018

1 reference

Intravenous immunoglobulin a natural regulator of immunity and inflammation

21 January 2018

1 reference

History of immunoglobulin replacement

21 January 2018

1 reference

Intravenous immunoglobulins--understanding properties and mechanisms

21 January 2018

1 reference

The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.

21 January 2018

1 reference

Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients

21 January 2018

1 reference

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

21 January 2018

1 reference

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection

21 January 2018

1 reference

Advances in diagnosing and managing antibody-mediated rejection

21 January 2018

1 reference

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis

21 January 2018

1 reference

Neuroprotection in stroke by complement inhibition and immunoglobulin therapy

21 January 2018

1 reference

Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition

21 January 2018

1 reference

Triggers of inflammation after renal ischemia/reperfusion

21 January 2018

1 reference

Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death

21 January 2018

1 reference

Targeting ischemic brain injury with intravenous immunoglobulin

21 January 2018

1 reference

F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

21 January 2018

1 reference

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

21 January 2018

1 reference

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

21 January 2018

1 reference

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

21 January 2018

1 reference

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

Identification of a receptor required for the anti-inflammatory activity of IVIG.

21 January 2018

1 reference

The antiinflammatory IgG.

21 January 2018

1 reference

DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells

21 January 2018

1 reference

Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation

21 January 2018

1 reference

New insight into the mechanism of action of IVIg: the role of dendritic cells

21 January 2018

1 reference

IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa

21 January 2018

1 reference

Gene Expression Profiling of the Effect of High-Dose Intravenous Ig in Patients with Kawasaki Disease

21 January 2018

1 reference

Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin

21 January 2018

1 reference

Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes

21 January 2018

1 reference

IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes

21 January 2018

1 reference

Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin

21 January 2018

1 reference

Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells

21 January 2018

1 reference

Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"

21 January 2018

1 reference

Immunomodulation by intravenous immunoglobulin: role of regulatory T cells

21 January 2018

1 reference

Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases

21 January 2018

1 reference

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

21 January 2018

1 reference

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

Presensitization: the problem and its management

21 January 2018

1 reference

Rituximab and intravenous immune globulin for desensitization during renal transplantation

21 January 2018

1 reference

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.11.10

1 reference

24 August 2017

1 reference